Outcomes of Kidney Grafts Refused by One or More Centers and Subsequently Transplanted at a Single United Kingdom Center

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1541-1546

  Farid, S ^a   Aldouri, A ^a   Fraser, S ^a   Al Mukhtar, A ^a   Newstead, C ^a   Lewington, A ^a   Baker, R ^a   Menon, K ^a   Ahmad, N ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; CYTOMEGALOVIRUS ANTIBODY; HEPATITIS B CORE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CHILD; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH CENTER; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DONOR; KIDNEY DUPLICATION; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY INJURY; KIDNEY SIZE; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ABANDONMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; UNITED KINGDOM;

CADAVER; GRAFT REJECTION; GRAFT SURVIVAL; GREAT BRITAIN; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME; TREATMENT REFUSAL; WAITING LISTS;

EID: 67249144027     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.088     Document Type: Article

References (19)

1. United Kingdom Transplant Activity Report. 2005-2006. http://www.uktransplant.org.uk/ukt/statistics/statistics.jsp Accessed February 22, 2008
2. Guidelines relating to solid organ transplants from non-heart beating donors: British Transplantation Society. http://www.bts.org.uk/standards.htm Accessed November 2004
3. Meier-Kriesche H.U., and Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes. Paired donor kidney analysis. Transplantation 74 (2002) 1377
4. The Cost Effectiveness of Kidney Transplantation: Statement from UK Transplant. http://www.uktransplant.org.uk/ukt Accessed January 2007
5. Perico N., Ruggenenti P., Scalamogna M., et al. Tackling the shortage donor kidneys; how to use the best that we have. Am J Nephrol 23 (2003) 245
6. Lopez-Navidad A., and Cabellero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing the organ pool. Clin Transplant 17 (2003) 308
7. Ramos E., Aoun S., and Harmon W. Expanding the donor pool: effect on graft outcome. J Am Soc Nephrol 13 (2002) 2590
8. Berthoux F. Evaluation and selection of donors. Nephrol Dial Transplant 15 (2000) 39
9. Bilgin N., Karakayali H., Moray G., et al. Outcome of renal transplantation from elderly donors. Transplant Proc 30 (1996) 744
10. Bryan C., Harell K., Mitchell S., et al. HLA points assigned in cadaveric kidney allocation should be revised: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant 3 (2003) 459
11. Su X., Zenios S., Chakkera H., et al. Diminished significance of HLA matching in kidney transplantation. Am J Transplant 4 (2004) 1501
12. Irish W.D., McCollum D.A., Raymond J.T., et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal recipients. J Am Soc Nephrol 14 (2003) 2967
13. Perico N., Cattaneo D., Sayegh M.H., et al. Delayed graft function in kidney transplantation. Lancet 364 (2004) 1814
14. Woo Y.M., Jardine A.G., Clark A.F., et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 55 (1999) 692
15. Becker Y.T., Leverson G.E., D'Alessandro A.M., et al. Diabetic kidneys can safely expand the donor pool. Transplantation 74 (2002) 141
16. Frei U., Schindler R., Wieters D., et al. Pre transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction. Nephrol Dial Transplant 10 (1995) 1206
17. Chan P.C.K., Lok A.S.F., Cheng I.K.P., et al. The impact of donor and recipient hepatitis B surface antigen status on liver disease and survival in renal transplant recipients. Transplantation 53 (1992) 128
18. Lumbreras C., Sanz F., Gonzalez A., et al. Clinical significance of donor unrecognised bacteraemia in the outcome of solid organ transplant recipients. Clin Infect Dis 33 (2001) 722
19. Welberry Smith M.P., Newstead C., and Ahmad N. Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation. Transplantation 85 (2008) 636